Evidence receipt / evaluation
Published · transcript-backedDavid Rosenthal: evaluation
27 Jul 2021 Acquired Andreessen Horowitz Part I
“That's a good question. It could be that or I wonder if it's more that if we were to cover this company, we would say you should not invest in this company.”
Source trail
Everything needed to verify it.
- Speaker
- David Rosenthal
- Attribution
- Verified speaker
- Claim type
- evaluation
- Recorded
- 27 Jul 2021
- Publisher
- Acquired
- Episode
- Andreessen Horowitz Part I
Transcript context
…What's the logic there? It’s just expensive to have analysts covering your company and they're like, look, we just don't believe in the company anymore even though we underwrote it, so we're going to stop paying analysts to do this work? That's a good question. It could be that or I wonder if it's more that if we were to cover this company, we would say you should not invest in this company. You should sell, and we don't really want to do that because we were just the book-runners on the IPO. It’s probably easier to just drop coverage. The logic of why they're dropping guidance is like, look, all the companies that we thought we're going to be customers are going out of business. We are a picks and shovels business for an industry that is going away.…
Stored transcript either side of the excerpt. The highlighted words are the published quote; the surrounding text is unedited source, never generated.